Practical Geriatrics ›› 2024, Vol. 38 ›› Issue (5): 521-437.doi: 10.3969/j.issn.1003-9198.2024.05.021
Previous Articles Next Articles
Received:2023-06-15
Online:2024-05-20
Published:2024-05-23
CLC Number:
| [1] CAMPISI J. Aging, cellular senescence, and cancer[J]. Annu Rev Physiol, 2013, 75: 685-705. [2] SHAKERI H, LEMMENS K, GEVAERT A B, et al.Cellular senescence links aging and diabetes in cardiovascular disease[J].Am J Physiol Heart Circ Physiol, 2018, 315(3):H448-H462. [3] CHILDS B G, DURIK M, BAKER D J, et al.Cellular senescence in aging and age-related disease: from mechanisms to therapy[J].Nat Med, 2015, 21(12):1424-1435. [4] MAGIANO D J, BOYKO E J, IDF Diabetes Atlas 10th edtion scientific committee. IDF Diabetes Atlas[M]. 10th ed. Brussels: International Diabetes Federation, 2021: 35. [5] LI Y, TENG D I, SHI X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study[J]. BMJ, 2020, 369. [6] HERNANDEZ-SEGURA A, NEHME J, DEMARIA M.Hallmarks of cellular senescence[J].Trends Cell Biol, 2018, 28(6):436-453. [7] ZHU M, LIU X, LIU W, et al.β cell aging and age-related diabetes[J].Aging: Albany NY, 2021, 13(5):7691-7706. [8] AN S, CHO S Y, KANG J, et al.Inhibition of 3-phosphoinositide–dependent protein kinase 1 (PDK1) can revert cellular senescence in human dermal fibroblasts[J].Proc Natl Acad Sci USA, 2020, 117(49):31535-31546. [9] HAYFLICK L.The limited in vitro lifetime of human diploid cell strains[J].Exp Cell Res, 1965, 37(3):614-636. [10] SCHMITT C A.The persistent dynamic secrets of senescence[J].Nat Cell Biol, 2016, 18(9):913-915. [11] ZHU Y I, TCHKONIA T, PIRTSKHALAVA T, et al.The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs[J].Aging Cell, 2015, 14(4):644-658. [12] HEIANZA Y, ARASE Y, FUJIHAR K, et al.Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA1c and impaired fasting glucose: the Toranomon Hospital Health Management Center Study 4 (TOPICS 4)[J].Diabet Med, 2012, 29(9):e279-e285. [13] THOMPSON P J, SHAH A, NTRANOS V, et al.Targeted elimination of senescent beta cells prevents type 1 diabetes[J].Cell Metab, 2019, 29(5):1040-1060. [14] MURAKAMI T, INAGAKI N, KONDOH H. Cellular senescence in diabetes mellitus: distinct senotherapeutic strategies for adipose tissue and pancreatic β cells[J]. Front Endocrinol (Lausanne), 2022, 13: 869414. [15] SOUMAYA K. Molecular mechanisms of insulin resistance in diabetes[J]. Adv Exp Med Biol, 2012, 771: 240-251. [16] ORMAZABAL V, NAIR S, ELFEKY O, et al. Association between insulin resistance and the development of cardiovascular disease[J]. Cardiovasc Diabetol, 2018, 17: 1-14. [17] LEE G, KIM Y Y, JANG H, et al. SREBP1c-PARP1 axis tunes anti-senescence activity of adipocytes and ameliorates metabolic imbalance in obesity[J]. Cell Metab, 2022, 34(5): 702-718. e5. [18] AGUAYO-MAZZUCATO C, ANDLE J, LEE T B, et al.Acceleration of β cell aging determines diabetes and senolysis improves disease outcomes[J].Cell Metab, 2019, 30(1):129-142. [19] KRISHNAMURTHY J, RAMSEY M R, LIGON K L, et al.p16INK4a induces an age-dependent decline in islet regenerative potential[J].Nature, 2006, 443(7110):453-457. [20] STEIN G H, DRULLINGER L F, SOULARD A, et al.Differential roles for cyclin-dependent kinase inhibitors p21 and p16 in the mechanisms of senescence and differentiation in human fibroblasts[J].Mol Cell Biol, 1999, 19(3):2109-2117. [21] SWISA A, KAESTNER K H, DOR Y.Transcriptional noise and somatic mutations in the aging pancreas[J].Cell Metab, 2017, 26(6):809-811. [22] AGUAYO-MAZZUCATO C, VAN HAAREN M, MRUK M, et al.Cell aging markers have heterogeneous distribution and are induced by insulin resistance[J].Cell Metab, 2017, 25(4):898-910. [23] TUDURIˊ E, SORIANO S, ALMAGRO L, et al. The pancreatic β-cell in ageing: Implications in age-related diabetes[J]. Ageing Res Rev, 2022, 80: 101674. [24] GU Z, DU Y, LIU Y, et al.Effect of aging on islet beta-cell function and its mechanisms in Wistar rats[J].Age, 2012, 34:1393-1403. [25] CAO Z, LIU Y, WANG Y, et al. Research progress on the role of PDGF/PDGFR in type 2 diabetes[J]. Biomed Pharmacother, 2023, 164: 114983. [26] HELMAN A, KLOCHENDLER A, AZAZMEH N, et al.p16 (Ink4a)-induced senescence of pancreatic beta cells enhances insulin secretion[J].Nat Med, 2016, 22(4):412-420. [27] MOIN A S M, BUTLER A E.Alterations in beta cell identity in type 1 and type 2 diabetes [J].Curr Diab Rep, 2019, 19:1-12. [28] WALI J A, MASTERS S L, THOMAS H E.Linking metabolic abnormalities to apoptotic pathways in Beta cells in type 2 diabetes[J].Cells, 2013, 2(2):266-283. [29] GUO S, DAI C, GUO M, et al.Inactivation of specific β cell transcription factors in type 2 diabetes[J].J Clin Invest, 2013, 123(8):3305-3316. [30] KOBAYASHI M, KIKUCHI O, SASAKI T, et al.FoxO1 as a double-edged sword in the pancreas: analysis of pancreas-and β-cell-specific FoxO1 knockout mice[J].Am J Physiol Endocrinol Metab, 2012, 302(5):E603-E613. [31] GAO T, MCKENNA B, LI C, et al. Pdx1 maintains β cell identity and function by repressing an α cell program[J]. Cell Metab, 2014, 19(2): 259-271. [32] WANG S Y, HALBAM P A, ROWE J W.Effects of aging on insulin synthesis and secretion. Differential effects on preproinsulin messenger RNA levels,proinsulin biosynthesis,and secretion of newly made and preformed insulin in the rat[J].J Clin Invest, 1998, 81(1):176-184. [33] SHIMIZU M, KAWAZU S, TOMONO S, et al.Age-related alteration of Pancreatic β-cell function: increased proinsulin and proinsulin-to-insulin molar ratio in elderly,but not in obese,subjects without glucose intolerance[J].Diabetes care, 1996, 19(1):8-11. [34] DHAWAN S, TSCHEN S I, ZENG C, et al.DNA methylation directs functional maturation of pancreatic β cells[J].J Clin Invest, 2015, 125(7):2851-2860. [35] AVRAHAMI D, LI C, ZHANG J, et al.Aging-dependent demethylation of regulatory elements correlates with chromatin state and improved β cell function[J].Cell Metab, 2015, 22(4):619-632. |
| [1] | WANG Su, ZHAO Yijing, WEI Chenmin, CHEN Kun, CAO Wen, WANG Kun, YANG Yu. Correlation of triglyceride-glucose index with low-density lipoprotein subtypes in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2024, 38(10): 1002-1006. |
| [2] | GU Chonghuai, XIANG Xuejun, ZHENG Yuanxi, QIAO Rui, LIN Song. Efficacy of dapagliflozin in elderly patients undergoing coronary intervention with type 2 diabetes mellitus and ejection fraction reduced heart failure [J]. Practical Geriatrics, 2024, 38(10): 1025-1029. |
| [3] | . [J]. Practical Geriatrics, 2024, 38(10): 1066-1069. |
| [4] | SHAN Zhuzi, WANG Xuefei, WU Haidi, LIU Dongmei, JIANG Hua, TANG Wei, MO Yongzhen, CUI Yan. Study on the relationship between percentage of body fat and blood glucose fluctuation in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2024, 38(7): 693-696. |
| [5] | LIU Qianhui, YAO Zijun, HE Yuli, XU Yunfan, WU Jun. Effects of HbA1c level on cardiac structure and function in elderly patients with type 2 diabetes mellitus and chronic heart failure [J]. Practical Geriatrics, 2024, 38(5): 491-437. |
| [6] | LIU Tongjun, ZHAO Yajie, HU Jieling, HU Yang, LIANG Wei. Effect of glucose metabolic disorders on serum levels of activin-A [J]. Practical Geriatrics, 2024, 38(5): 495-437. |
| [7] | . [J]. Practical Geriatrics, 2024, 38(5): 529-437. |
| [8] | TANG Yuan, DENG Shufang, HE Yongmei, DAI Yuxuan, LUO Jing. The status of health literacy and correlation with frailty in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2024, 38(3): 255-259. |
| [9] | HONG Bing, XU Xiao-Wen, YU Wei-Nan, XU Wei, HU Wen. Application of glargine in elderly type 2 diabetic patients during perioperative period [J]. Practical Geriatrics, 2010, 24(2): 132-134. |
| [10] | ZHU Jian-Yi, LV Zhi-Gang, SHI Heng-Chuan. Relationship of serum total homocysteine and macrovascular diseases in elderly patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2010, 24(2): 135-137. |
| [11] | WU Hai-Di, BIAN Rong-Wen, HU Yan. Safety and variation of blood potassium during argentine stimulation test in patients with type 2 diabetes mellitus [J]. Practical Geriatrics, 2010, 24(2): 138-140. |
| [12] | HU Lan-Ping, GU Ping, WANG Jian, SHAO Jia-Qiang, DU Hong, WANG Yang-Tian, LU Bin, PENG Li. Determination of islet autoantibodies in elderly diabetic patients by immunoblotting test [J]. Practical Geriatrics, 2010, 24(2): 156-158. |
| [13] | . [J]. Practical Geriatrics, 2024, 38(4): 410-413. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
|
